Imatinib mesylate 400mg Tablet
Prescription Required
Manufactured By
Pack of
3x10 tablet
Salt Composition
Imatinib mesylate
Storage
Keep in cold place
Delivering To: —
All Substitutes
Overview
Imatinib mesylate 400mg Tablet belongs to a class of medication known as tyrosine kinase inhibitors. It is an anticancer medicine that is commonly prescribed to treat certain blood cancers like chronic myeloid leukemia & acute lymphocytic leukemia, and gastrointestinal stromal tumors. It works as a specific inhibitor of several tyrosine kinase enzymes. After the oral administration, the effect of this medicine can be observed in 2-4 hours.
Indication
Blood Cancer
Side Effects
Like any other medicine, Imatinib mesylate 400mg Tablet also has some adverse effects on the body, and most of them are manageable without special medical attention.
Some common side effects include:
Difficulty in breathing
Indigestion
Constipation
Weight loss
Acidic stomach
Change in taste
Dry mouth
Joint pain
Irregular heartbeat
Unusual bleeding
Presence of blood in coughing
Abdominal pain.
Swelling around the eyes
Do not forget to discuss the risks and benefits of this medication with your doctor. Seek medical attention immediately in case of any severe issues.
How To Use
TakeImatinib mesylate 400mg Tablet as prescribed by your doctor. Swallow it as a whole with water and don't chew, crush, or break it. This tablet should be taken with food. Take it at the same time every day for effective results.
Safety Advice
Alcohol
unsafe
The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Imatinib 400mg Tablet.
Pregnancy
consult your doctor
Do not take Imatinib 400mg Tablet without consulting the doctor in case of pregnancy.
Breast Feeding
consult your doctor
Imatinib 400mg Tablet is unsafe to use during breastfeeding as it may cause toxicity to the baby. It is safe if prescribed.
Driving
danger
Imatinib 400mg Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Kidney
caution
Consumption of Imatinib 400mg Tablet should be avoided without informing the doctor if you have any kidney-related issues.
Liver
caution
Consumption of Imatinib 400mg Tablet should be avoided without informing the doctor if you have any liver-related issues.
Missed Doses
It is advisable not to miss a dose of Imatinib 400mg Tablet. If you miss a scheduled dose of this medicine, contact your doctor immediately.
Quick Tips
FAQs
Imatinib tablet is used to treat certain types of cancer, such as chronic myeloid leukemia, acute lymphocytic leukemia, and gastrointestinal stromal tumors.
This is an anti-cancer medication. This medication belongs to a class of medicines known as tyrosine kinase inhibitors. This medicine stops the growth of cancer cells and also prevents the multiplication of cancer cells.
Some common side effects of the Imatinib tablet are abdominal pain, fatigue, anxiety, vomiting, muscle pain, nausea, rash, joint pain, difficulty in breathing, etc.
It is not known whether it is safe or not. Please consult your doctor before consuming alcohol while taking this medicine.
This medicine is not recommended for breastfeeding unless it is necessary.
Reference
1.https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf
2.https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021588s047lbl.pdf
3.Cohen, M. H., Johnson, J. R., & Pazdur, R. (2005). US Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval. Clinical cancer research, 11(1), 12-19.
4.Nikolova, Z., Peng, B., Hubert, M., Seiberling, M., Keller, U., Ho, Y. Y., ... & Capdeville, R. (2004). Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules. Cancer chemotherapy and pharmacology, 53(5), 433-438.
Devi, N. A., Hadi, M. A., Rajitha, P., Sharma, J. V. C., & Rao, A. S. (2013). Formulation and evaluation of floating controlled release tablets of imatinib mesylate using hydrophilic matrix system. Int J Pharm Pharm Sci, 5(1), 271-277.
Related Products
MARKETER DETAILS
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.